S100B and concussion: The blood-based biomarker S100B is Conformité Européenne (CE) marked; is used in clinical practice in several European countries, including France; and has been incorporated into the Scandinavian guidelines.7,8 Subsequently, a prospective study found that incorporating S100B into the guidelines for management of mTBI was cost saving.8